Company intelligence / Profile preview

KKVS Syndicate

Ownership: Private
Development stage: Other

Overview

KKVS Syndicate is a specialized investment group and syndicate focused on the life sciences and healthcare sectors. The organization typically operates by pooling capital from private investors to fund early-stage biotechnology companies, medical device startups, and healthcare service providers. While not a drug developer itself, KKVS Syndicate plays a critical role in the biotech ecosystem by providing seed and Series A funding to innovative ventures. Their portfolio often includes companies working on novel therapeutics and digital health solutions.

Industry: Investors

Beyond the preview

Go deeper on KKVS Syndicate.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on KKVS Syndicate.

Explore the full profile